Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binsah George

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Blood|January 10, 2015
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinibPreetesh Jain, Michael Keating, William Wierda, et al.
Cancer|April 5, 2023
Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicityMax J Gordon, Jade E Jones, Binsah George, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Cancer Medicine|October 16, 2018
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitorsAlejandro Zulbaran-Rojas, Huei-Kan Lin, Qiuling Shi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Blood|January 10, 2015
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinibPreetesh Jain, Michael Keating, William Wierda, et al.
Cancer|April 5, 2023
Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicityMax J Gordon, Jade E Jones, Binsah George, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Cancer Medicine|October 16, 2018
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitorsAlejandro Zulbaran-Rojas, Huei-Kan Lin, Qiuling Shi, et al.
Pageof 2